Search clinical trials for: Protease inhibitor
Total 64564 results
-
Neosil, Inc.UnknownAndrogenetic AlopeciaGermany
-
Neosil, Inc.Completed
-
The Rogosin InstituteWeill Medical College of Cornell UniversityWithdrawn
-
University of FlorenceAzienda Ospedaliero-Universitaria Careggi; Istituto per lo Studio, la Prevenzione...Recruiting
-
National Institute of Dental and Craniofacial Research...Completed
-
Steven E. CoutreNational Cancer Institute (NCI)TerminatedRecurrent Adult Acute Myeloid Leukemia | Adult Acute Megakaryoblastic Leukemia (M7) | Adult Acute Minimally Differentiated Myeloid Leukemia (M0) | Adult Acute Monoblastic Leukemia (M5a) | Adult Acute Monocytic Leukemia (M5b) | Adult Acute Myeloblastic Leukemia With Maturation (M2) | Adult Acute... and other conditionsUnited States
-
American Society of HematologyActive, not recruitingBenign and Malignant Hematologic DiseasesUnited States
-
Grifols Therapeutics LLCTerminatedCOVID-19United States, Brazil, Chile, Colombia, Mexico
-
University of DundeeRecruitingBronchiectasis AdultUnited Kingdom
-
Children's Hospital Medical Center, CincinnatiNational Institutes of Health (NIH); CSL BehringRecruiting
-
Institute for Human Genetics and BiochemistryCSL BehringCompleted
-
Panineeya Mahavidyalaya Institute of Dental Sciences...CompletedPulmonary Disease, Chronic Obstructive | Generalized Chronic PeriodontitisIndia
-
CSL BehringCompletedEmphysema | Alpha1-proteinase Inhibitor DeficiencyAustralia, Russian Federation, United States, Denmark, Estonia, Finland, Germany, Ireland, Poland, Romania, Sweden, Canada, Czech Republic
-
University of Colorado, DenverCompletedHepatitis C | HIV CoinfectionUnited States
-
CelgeneCompletedMelanoma | Lymphoma | Multiple Myeloma | Pancreatic Cancer | Non-Small Cell Lung CancerAustralia
-
Baxalta now part of ShireCompletedAlpha1-antitrypsin DeficiencyUnited States, Canada
-
Baxalta now part of ShireTerminated
-
Baxalta now part of ShireBaxter Healthcare, Ltd. (New Zealand), Baxter Healthcare Pty. Ltd. (Australia)CompletedAlpha 1-Antitrypsin DeficiencyAustralia, New Zealand
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI); National Heart, Lung, and Blood Institute...CompletedGraft-Versus-Host Disease (GVHD) Acute on ChronicUnited States
-
Baxalta now part of ShireCompletedAlpha 1-Antitrypsin DeficiencyNew Zealand, Australia
-
Grifols Therapeutics LLCCompletedEmphysema | Alpha 1-antitrypsin Deficiency (AATD)United States
-
H. Lee Moffitt Cancer Center and Research InstituteAdaptive BiotechnologiesRecruitingMultiple MyelomaUnited States
-
Baxalta now part of ShireCompleted
-
Kamada, Ltd.CompletedEmphysemaUnited Kingdom, Canada, Denmark, Germany, Ireland, Netherlands, Sweden
-
Instituto Grifols, S.A.Completed
-
CSL BehringCompletedEmphysema | Alpha 1-proteinase Inhibitor DeficiencyAustralia, Canada, Czech Republic, Denmark, Estonia, Finland, Germany, Ireland, Poland, Romania, Sweden
-
Michael Campos, MDCSL BehringCompletedAlpha 1 Antitrypsin DeficiencyUnited States
-
Blessing Corporate Services, IncTakeda Pharmaceuticals North America, Inc.Withdrawn
-
ShireWithdrawnChronic Obstructive Pulmonary Disease | Alpha1-antitrypsin Deficiency
-
CSL BehringRecruitingAcute-graft-versus-host DiseaseUnited States, Korea, Republic of, Spain, Australia, Germany, Italy, Turkey, Japan
-
Institute for Human Genetics and BiochemistryGrifols Biologicals, LLC; AIDS Community Research Initiative of AmericaTerminated
-
Boehringer IngelheimCompletedHIV InfectionsUnited States, Puerto Rico
-
National Institute of Allergy and Infectious Diseases...Juvenile Diabetes Research Foundation; Immune Tolerance Network (ITN)WithdrawnDiabetes Mellitus, Type 1United States
-
Grifols Therapeutics LLCRecruiting
-
TakedaWithdrawnChronic Obstructive Pulmonary Disease (COPD) | Alpha1-Antitrypsin Deficiency
-
University of MinnesotaNational Institute of Allergy and Infectious Diseases (NIAID)RecruitingCOVID-19United States, Singapore, Japan, Ukraine, Georgia, Korea, Republic of, Australia, Denmark, Thailand, Greece, South Africa, Germany, Uganda, Spain, Puerto Rico, Argentina, Nigeria, United Kingdom, Brazil
-
Techpool Bio-Pharma Co., Ltd.Center for ADR Monitoring of GuangdongUnknown
-
Techpool Bio-Pharma Co., Ltd.The First Affiliated Hospital of Guangzhou Medical UniversityUnknownAcute Respiratory Distress SyndromeChina
-
Seoul National University HospitalRecruitingAtrial Fibrillation | Anticoagulant-induced BleedingKorea, Republic of
-
Medical Research CouncilNHS Health Technology Assessment ProgrammeUnknownAcquired Immunodeficiency Syndrome | HIV Infection
-
CSL BehringNational Cancer Institute (NCI); National Heart, Lung, and Blood Institute... and other collaboratorsActive, not recruitingGraft Versus Host Disease (GVHD)United States
-
Kamada, Ltd.CompletedNew Onset Type-1 DiabetesIsrael
-
Peking Union Medical College HospitalTechpool Bio-Pharma Co., Ltd.CompletedSepsis | Septic ShockChina
-
Soroka University Medical CenterUnknownPost Cardiac Surgery Systemic Inflammatory Response
-
University of ChicagoRecruitingKidney Transplantation | End Stage Kidney Disease (ESRD)United States
-
Janssen R&D IrelandCompletedHuman Immunodeficiency Virus Type 1United States, France, United Kingdom, Belgium, Spain, Switzerland, Sweden, Canada, Puerto Rico, Poland
-
Pauls Stradins Clinical University HospitalActive, not recruitingAtherosclerotic Cardiovascular DiseaseLatvia
-
French National Agency for Research on AIDS and...TerminatedHIV Infections | HIV-Associated Lipodystrophy SyndromeFrance
-
John LevineNational Cancer Institute (NCI)CompletedGVHD | Graft-versus-host-diseaseUnited States